9/19/2020 1:11:37 PM
AZN : TAGRISSO Reduces Risk Of Disease Recurrence In Brain By 82% In Adjuvant Treatment Of EGFR-Mutated Lung Cancer
9/18/2020 7:06:28 AM
AstraZeneca And Merck Announce LYNPARZA Demonstrates Long-term Progression-free Survival Benefit Versus Placebo
9/12/2020 12:53:42 PM
AstraZeneca Resumes Covid-19 Vaccine Trial In UK
9/10/2020 2:12:45 AM
AstraZeneca To List US ADR Equity And US Debt Securities On Nasdaq; ADR Ticker Symbol To Remain AZN
9/10/2020 2:09:49 AM
AstraZeneca Says Fasenra PhIII OSTRO Trial Meets Co-primary Endpoints
9/1/2020 2:12:58 AM
Oxford Biomedica Signs Supply Deal With AstraZeneca To Expand Manufacturing Support Of AZD1222
9/1/2020 2:04:08 AM
AstraZeneca Says Farxiga Reduces CKD Progression And Risk Of Death In Phase III DAPA-CKD Trial
9/1/2020 2:02:45 AM
AstraZeneca Says Imfinzi Approved In The EU For Extensive-stage Small Cell Lung Cancer
8/31/2020 5:18:18 PM
Development Of COVID-19 Vaccine AZD1222 Expands Into US Phase III Clinical Trial Across All Adult Age Groups
8/25/2020 2:04:28 AM
AstraZeneca Begins Phase I Trial Of AZD7442 For Monoclonal Antibody Combination
for COVID-19